More evidence on blocking the renin-angiotensin-aldosterone system in cardiovascular disease and the long-term treatment of hypertension: data from recent clinical trials (CHARM, EUROPA, ValHEFT, HOPE-TOO and SYST-EUR2).

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

7 citing papers in PubMed.

1. Reappraisal of role of angiotensin receptor blockers in cardiovascular protection.Vascular health and risk management · 2011
   Review
2. Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies.Heart failure reviews · 2008
   Review
3. Evolving treatment options for prevention of cardiovascular events in high-risk hypertensive patients.Journal of clinical hypertension (Greenwich, Conn.) · 2007
   Review
4. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.Drugs & aging · 2006
   Review
5. Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists' Collaboration meta-analysis.Journal of human hypertension · 2005
   Article
6. Angiotensin-II receptor blockers: benefits beyond blood pressure reduction?Journal of human hypertension · 2005
   Review
7. Atherosclerotic renal artery stenosis, ACE inhibitors, and avoiding cardiovascular death.Heart (British Cardiac Society) · 2005
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as